SOURCE: HealthSonix

August 30, 2006 11:00 ET

Dr. Edward C. Keystone Joins HealthSonix Medical Advisory Board

IRVINE, CA -- (MARKET WIRE) -- August 30, 2006 -- HealthSonix Inc. (PINKSHEETS: HSXI) is pleased to announce that Edward C. Keystone M.D., FRCP(C) has joined company's Medical and Scientific Advisory Board to provide guidance, for ongoing clinical research.

"Dr. Keystone's international experience and dedication in the field of Rheumatology will be an invaluable asset to our company as we enter a new growth phase," said Dr. David Venturi, Medical Director of HealthSonix. "I personally look forward to a very productive and enlightening relationship with Dr. Keystone."

Dr. Keystone is a professor of Medicine at the University of Toronto; Chairman of the Canadian Rheumatology Research Consortium; Associate Clinical Director of the Canadian Arthritis Network; founder and Board member of The Arthritis & Autoimmunity Research Centre of the University Health Network, one of the most comprehensive research centres of its kind in the world; and Senior Consultant, Rheumatology, at Mount Sinai.

Dr. Keystone recently established The Rebecca Macdonald Centre for Arthritis and Autoimmune Disease at Mount Sinai Hospital -- a centre devoted to research into genomics, therapeutics, and outcomes in autoimmune inflammatory joint disease and osteoarthritis. He is Director of the Centre and heads the Advanced Therapeutics Division which focuses on novel therapeutics.

He is also a consultant to the pharmaceutical and biotechnology industry worldwide, and is a member of numerous biopharmaceutical advisory boards. He is the author of more than 165 peer-reviewed papers, reviews, and book chapters and has been the recipient of numerous teaching awards and honors, including the Senior Investigator Award of the Canadian Rheumatology Association.

HealthSonix Inc. (PINKSHEETS: HSXI) is a publicly traded medical technology company. The Company's core offerings are based on a proprietary, patent pending medical technology that uses sound pressure waves to administer sub-sensory micro vibration to the human body for therapeutic purposes. The first application, AquaSonix Therapy, is a breakthrough medical treatment for people with pain, reduced mobility and diminishing flexibility. This therapeutic water program combines, (1) sound pressure waves with (2) individualized low impact exercises in (3) warm water therapy pools.

More information regarding HealthSonix and its products and services can be found at: www.HealthSonix.com or by calling the company at 1-877-622-2121.

Note: A number of statements contained in this report are forward-looking statements, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, competitive market conditions, successful integration of acquisitions, the ability to secure additional sources of financing, the ability to reduce operating expenses and other factors not set forth herein. The actual results that the Company may achieve may differ materially from any forward-looking statements due to such risks and uncertainties.

Contact Information